| 1 | Pyoderma Gangrenosum | 30.2% |
| 2 | Giant Cell Tumor of Bone | 29.6% |
| 3 | Chondrosarcoma | 29.1% |
| 4 | synovial sarcoma | 29.1% |
| 5 | Clear Cell Sarcoma of Soft Tissue | 29.1% |
| 6 | Dermatitis, Atopic | 27.6% |
| 7 | Dermatitis, Photoallergic | 25.4% |
| 8 | Myxoma | 25% |
| 9 | Neoplasms, Bone Tissue | 25% |
| 10 | Neoplasms, Fibrous Tissue | 25% |
| 11 | Chondroma | 25% |
| 12 | Enchondroma | 25% |
| 13 | Dermatitis, Phototoxic | 24.7% |
| 14 | Pityriasis Lichenoides et Varioliformis Acuta | 24.7% |
| 15 | Pityriasis Lichenoides | 24.7% |
| 16 | Phototoxicity | 24.7% |
| 17 | Serum Sickness | 24.5% |
| 18 | Acne Vulgaris | 24.2% |
| 19 | Contact Dermatitis | 24.2% |
| 20 | Eczema | 24.2% |
| 21 | Erythema Multiforme | 24.2% |
| 22 | Intertrigo | 24.2% |
| 23 | Neurodermatitis | 24.2% |
| 24 | Rhinophyma | 24.2% |
| 25 | Perioral Dermatitis | 24.2% |
| 26 | Acne | 24.2% |
| 27 | Fibrosarcoma | 24.1% |
| 28 | Osteosarcoma | 24.1% |
| 29 | Dermatitis Herpetiformis | 23.7% |
| 30 | Xeroderma Pigmentosum | 23.5% |
| 31 | Dermatitis, Allergic Contact | 23.2% |
| 32 | Epidermolysis Bullosa | 22.6% |
| 33 | Lupus Erythematosus, Cutaneous | 22.1% |
| 34 | Panniculitis | 22.1% |
| 35 | Systemic Scleroderma | 22.1% |
| 36 | Morphea | 22.1% |
| 37 | Foot Ulcer | 22% |
| 38 | Sebaceous Gland Neoplasms | 21.8% |
| 39 | Malignant Fibrous Histiocytoma | 21.6% |
| 40 | Panniculitis, Lupus Erythematosus | 20.9% |
| 41 | Breast Diseases | 20.5% |
| 42 | Dermatitis | 20.5% |
| 43 | Exanthema | 20.5% |
| 44 | Facial Dermatoses | 20.5% |
| 45 | Hair Diseases | 20.5% |
| 46 | Hand Dermatoses | 20.5% |
| 47 | keratoacanthoma | 20.5% |
| 48 | Keratosis | 20.5% |
| 49 | Nail Diseases | 20.5% |
| 50 | Photosensitivity Disorders | 20.5% |
| 51 | Prurigo | 20.5% |
| 52 | Pyoderma | 20.5% |
| 53 | Rosacea | 20.5% |
| 54 | Sebaceous Gland Diseases | 20.5% |
| 55 | Skin Diseases, Vesiculobullous | 20.5% |
| 56 | Skin Ulcer | 20.5% |
| 57 | Sweat Gland Diseases | 20.5% |
| 58 | Skin Diseases, Papulosquamous | 20.5% |
| 59 | Skin Diseases, Vascular | 20.5% |
| 60 | Acneiform Eruptions | 20.5% |
| 61 | Ocular Rosacea | 20.5% |
| 62 | Subcorneal pustular dermatosis | 20.5% |
| 63 | Erythematotelangiectatic Rosacea | 20.5% |
| 64 | Papulopustular Rosacea | 20.5% |
| 65 | Chronic Actinic Dermatitis | 20.5% |
| 66 | Urticaria | 20.1% |
| 67 | Acrodermatitis | 20.1% |
| 68 | Porokeratosis | 20.1% |
| 69 | Gianotti-Crosti Syndrome | 20.1% |
| 70 | Keratoderma, Palmoplantar | 20.1% |
| 71 | Skin Neoplasms | 20% |
| 72 | Dermatitis, Irritant | 19.9% |
| 73 | Acne Conglobata | 19.9% |
| 74 | Erythema Nodosum | 19.8% |
| 75 | Toxic Epidermal Necrolysis | 19.7% |
| 76 | Stevens-Johnson Syndrome | 19.7% |
| 77 | Necrobiosis Lipoidica Diabeticorum | 19.5% |
| 78 | Dermatofibrosarcoma | 19.2% |
| 79 | Dermatofibrosarcoma Protuberans | 19.2% |
| 80 | Vasculitis, Leukocytoclastic, Cutaneous | 18.8% |
| 81 | fibroma | 18.7% |
| 82 | Fibromatosis | 18.7% |
| 83 | Osteoblastoma | 18.7% |
| 84 | Osteoma | 18.7% |
| 85 | Chondromatosis | 18.7% |
| 86 | leiomyosarcoma | 18.5% |
| 87 | liposarcoma | 18.5% |
| 88 | Angiomyolipoma | 18.5% |
| 89 | Alveolar Soft Part Sarcoma | 18.5% |
| 90 | Erythema Induratum | 18.2% |
| 91 | Diaper Rash | 17.8% |
| 92 | Sarcoma | 17.6% |
| 93 | Xeroderma | 17.4% |
| 94 | Dermatitis, Occupational | 17.1% |
| 95 | Foot Diseases | 17% |
| 96 | Drug Eruptions | 16.8% |
| 97 | Gastrointestinal Stromal Tumors | 16.7% |
| 98 | Skin Abnormalities | 16.6% |
| 99 | Skin Diseases, Infectious | 16.6% |
| 100 | Pigmentation Disorders | 16.6% |
| 101 | Papillon-Lefevre Disease | 16.5% |
| 102 | Lipomatosis | 16.3% |
| 103 | Pemphigus | 16.3% |
| 104 | Pruritus | 16.3% |
| 105 | Erythema | 16.3% |
| 106 | Necrolytic Migratory Erythema | 16.3% |
| 107 | Cutaneous Fistula | 16.3% |
| 108 | Nephrogenic Fibrosing Dermopathy | 16.3% |
| 109 | Nephrogenic Systemic Fibrosis | 16.3% |
| 110 | Adenofibroma | 16.3% |
| 111 | Fibroadenoma | 16.3% |
| 112 | Lupus Erythematosus, Discoid | 16.1% |
| 113 | Scleroderma, Limited | 16.1% |
| 114 | Erythema Infectiosum | 15.9% |
| 115 | Exanthema Subitum | 15.8% |
| 116 | Breast Cyst | 15.6% |
| 117 | Actinic keratosis | 15.6% |
| 118 | Fibromatosis, Aggressive | 15.5% |
| 119 | Fibromatosis, Abdominal | 15.5% |
| 120 | Dermatomyositis | 15.4% |
| 121 | Latex allergy | 15.4% |
| 122 | Carcinosarcoma | 15.3% |
| 123 | Hemangiosarcoma | 15.3% |
| 124 | lymphangiosarcoma | 15.3% |
| 125 | Hyperkeratosis, Epidermolytic | 15.2% |
| 126 | Anhidrosis | 15.1% |
| 127 | Cholesteatoma | 15.1% |
| 128 | Pressure Ulcer | 15.1% |
| 129 | Folliculitis | 15.1% |
| 130 | Foot Dermatoses | 15.1% |
| 131 | Gynecomastia | 15.1% |
| 132 | Hypertrichosis | 15.1% |
| 133 | Hypohidrosis | 15.1% |
| 134 | Hypotrichosis | 15.1% |
| 135 | Leg Ulcer | 15.1% |
| 136 | Miliaria | 15.1% |
| 137 | Parakeratosis | 15.1% |
| 138 | Parapsoriasis | 15.1% |
| 139 | Pityriasis | 15.1% |
| 140 | Psoriasis | 15.1% |
| 141 | Sweet Syndrome | 15.1% |
| 142 | Hidradenitis | 15.1% |
| 143 | Onycholysis | 15.1% |
| 144 | Miliaria Rubra | 15.1% |
| 145 | Hyperpigmentation | 15.1% |
| 146 | Lichenoid Eruptions | 15.1% |
| 147 | Chloracne | 15.1% |
| 148 | Ectodermal Dysplasia | 15.1% |
| 149 | Aplasia Cutis Congenita | 15.1% |
| 150 | Dupuytren Contracture | 15% |
| 151 | Tinea Capitis | 14.8% |
| 152 | Onychomycosis | 14.8% |
| 153 | Pseudoxanthoma Elasticum | 14.8% |
| 154 | Cutis Laxa | 14.7% |
| 155 | Rhabdomyosarcoma | 13.8% |
| 156 | Neurofibrosarcoma | 13.7% |
| 157 | Ecthyma | 13.6% |
| 158 | Carcinoma, Lobular | 13.4% |
| 159 | Angioedema | 13.4% |
| 160 | Sarcoma, Myeloid | 13.2% |
| 161 | Ichthyosis, X-Linked | 13.2% |
| 162 | Acute Generalized Exanthematous Pustulosis | 13.2% |
| 163 | Sjogren-Larsson Syndrome | 13.1% |
| 164 | leukemia | 12.8% |
| 165 | Neoplasms, Germ Cell and Embryonal | 12.8% |
| 166 | Neoplasms, Glandular and Epithelial | 12.8% |
| 167 | Germ Cell Cancer | 12.8% |
| 168 | Granuloma Annulare | 12.8% |
| 169 | Environmental Illness | 12.8% |
| 170 | Lichen Planus | 12.5% |
| 171 | Melanosis | 12.5% |
| 172 | Chloasma | 12.5% |
| 173 | Pityriasis Rosea | 12.5% |
| 174 | Pityriasis Rubra Pilaris | 12.5% |
| 175 | Vitiligo | 12.5% |
| 176 | Lichen Nitidus | 12.5% |
| 177 | Hidradenitis Suppurativa | 12.4% |
| 178 | Acantholysis | 12.2% |
| 179 | Behcet Syndrome | 12.2% |
| 180 | Pemphigoid, Benign Mucous Membrane | 12.2% |
| 181 | Piedra | 12.2% |
| 182 | Sunburn | 12.2% |
| 183 | Argyria | 12.1% |
| 184 | Hirsutism | 12.1% |
| 185 | Lactation Disorder | 12.1% |
| 186 | Mastitis | 12.1% |
| 187 | Neuroectodermal Tumors | 12.1% |
| 188 | Adiposis Dolorosa | 12% |
| 189 | Pruritus Vulvae | 12% |
| 190 | Breast Neoplasms, Male | 12% |
| 191 | Triple Negative Breast Neoplasms | 12% |
| 192 | Carcinoma 256, Walker | 12% |
| 193 | Pruritus Ani | 12% |
| 194 | Phyllodes Tumor | 11.7% |
| 195 | Lipoma | 11.7% |
| 196 | Myoma | 11.7% |
| 197 | Angiolipoma | 11.7% |
| 198 | Myelolipoma | 11.7% |
| 199 | Smooth Muscle Tumor | 11.7% |
| 200 | Desmoplastic Small Round Cell Tumor | 11.7% |
| 201 | Tinea Pedis | 11.6% |
| 202 | Neoplasms, Neuroepithelial | 11.6% |
| 203 | Gliomatosis cerebri | 11.6% |
| 204 | Alveolar rhabdomyosarcoma | 11.5% |
| 205 | Acanthosis Nigricans | 11.2% |
| 206 | Alopecia Areata | 11.2% |
| 207 | Lentigo | 11.2% |
| 208 | Albinism | 11% |
| 209 | Erythema Chronicum Migrans | 10.8% |
| 210 | Lymphangioleiomyomatosis | 10.8% |
| 211 | Lymphoma | 10.7% |
| 212 | Hereditary Angioedema Type III | 10.6% |
| 213 | Hereditary Angioedema Types I and II | 10.6% |
| 214 | Connective Tissue Diseases | 10.6% |
| 215 | Sarcoma, Experimental | 10.6% |
| 216 | Histiocytic Disorders, Malignant | 10.2% |
| 217 | Dermatomycoses | 10.2% |
| 218 | Mucocutaneous Lymph Node Syndrome | 10.2% |
| 219 | Skin Diseases, Bacterial | 10.2% |
| 220 | Kounis Syndrome | 10.2% |
| 221 | Alopecia | 10.1% |
| 222 | Sweating, Gustatory | 10.1% |
| 223 | Androgenetic Alopecia | 10.1% |
| 224 | Auriculotemporal Syndrome | 10.1% |
| 225 | anaphylaxis | 10.1% |
| 226 | Food Allergy | 10.1% |
| 227 | Anaphylactic shock | 10.1% |
| 228 | Lipodystrophy | 10.1% |
| 229 | Livedo Reticularis | 10.1% |
| 230 | Malignant Atrophic Papulosis | 10.1% |
| 231 | Asthma, Aspirin-Induced | 10% |
| 232 | Angioedemas, Hereditary | 10% |
| 233 | Lice Infestations | 10% |
| 234 | Varicose Ulcer | 10% |
| 235 | Composite Lymphoma | 10% |
| 236 | Leukemia, Plasma Cell | 9.9% |
| 237 | Polyarteritis Nodosa | 9.9% |
| 238 | Takayasu Arteritis | 9.9% |
| 239 | Galactorrhea | 9.9% |
| 240 | Urticaria Pigmentosa | 9.9% |
| 241 | melanoma | 9.9% |
| 242 | Mycetoma | 9.9% |
| 243 | Lupus Erythematosus, Systemic | 9.7% |
| 244 | Overlap syndrome | 9.7% |
| 245 | Meningioma | 9.2% |
| 246 | Endometrial Stromal Sarcoma | 9.1% |
| 247 | Lichen Planus, Oral | 9.1% |
| 248 | Sarcoma 180 | 9% |
| 249 | Autoimmune Diseases | 8.8% |
| 250 | Immunologic Deficiency Syndromes | 8.8% |
| 251 | Immunoproliferative Disorders | 8.8% |
| 252 | Immune reconstitution syndrome | 8.8% |
| 253 | Immune Reconstitution Inflammatory Syndrome | 8.8% |
| 254 | Nail-Patella Syndrome | 8.8% |
| 255 | Plasmacytoma | 8.7% |
| 256 | Rhabdomyoma | 8.7% |
| 257 | Porphyrias, Hepatic | 8.7% |
| 258 | Medulloblastoma | 8.6% |
| 259 | Peutz-Jeghers Syndrome | 8.5% |
| 260 | Larva Migrans | 8.4% |
| 261 | Leishmaniasis | 8.4% |
| 262 | Molluscum Contagiosum | 8.4% |
| 263 | Respiratory Hypersensitivity | 8.4% |
| 264 | Onchocerciasis | 8.3% |
| 265 | Chromoblastomycosis | 8.3% |
| 266 | Dermatophytosis | 8.3% |
| 267 | Sporotrichosis | 8.3% |
| 268 | Tinea | 8.3% |
| 269 | Tinea Versicolor | 8.3% |
| 270 | Trichophytosis | 8.3% |
| 271 | Hyalohyphomycosis | 8.3% |
| 272 | Adenoma, Acidophil | 8.2% |
| 273 | Ganglioneuroma | 8.2% |
| 274 | Glioma | 8.2% |
| 275 | Malignant Glioma | 8.2% |
| 276 | Sick Building Syndrome | 8.2% |
| 277 | Multiple Chemical Sensitivity | 8.2% |
| 278 | Primary amyloidosis | 8.1% |
| 279 | Hamartoma | 8% |
| 280 | Neoplasms, Hormone-Dependent | 8% |
| 281 | Neoplasms, Multiple Primary | 8% |
| 282 | Paraneoplastic Syndromes | 8% |
| 283 | Precancerous Conditions | 8% |
| 284 | Neoplasms, Second Primary | 8% |
| 285 | Basal cell carcinoma | 7.9% |
| 286 | Carcinoma, Papillary | 7.9% |
| 287 | Squamous cell carcinoma | 7.9% |
| 288 | Craniopharyngioma | 7.9% |
| 289 | Cystadenoma | 7.9% |
| 290 | Mesothelioma | 7.9% |
| 291 | Neuroectodermal Tumor, Melanotic | 7.9% |
| 292 | Neuroendocrine Tumors | 7.9% |
| 293 | Carcinoma, Basal Cell | 7.9% |
| 294 | Trophoblastic Neoplasms | 7.9% |
| 295 | Leukemia, Experimental | 7.9% |
| 296 | Melanoma, Experimental | 7.6% |
| 297 | Adenoma | 7.6% |
| 298 | Ameloblastoma | 7.6% |
| 299 | Angiokeratoma | 7.6% |
| 300 | Carcinoma | 7.6% |
| 301 | Chordoma | 7.6% |
| 302 | Hemangioma | 7.6% |
| 303 | hemangiopericytoma | 7.6% |
| 304 | Lymphangioma | 7.6% |
| 305 | Mesenchymoma | 7.6% |
| 306 | Nevus | 7.6% |
| 307 | Teratoma | 7.6% |
| 308 | Hepatoblastoma | 7.6% |
| 309 | Mixed Tumor, Mullerian | 7.6% |
| 310 | Germinoma | 7.6% |
| 311 | Teratocarcinoma | 7.6% |
| 312 | Angiofibroma | 7.6% |
| 313 | Epithelioma | 7.6% |
| 314 | Milk Allergy | 7.5% |
| 315 | Wheat Hypersensitivity | 7.5% |
| 316 | Myxoid cyst | 7.5% |
| 317 | Leishmaniasis, Cutaneous | 7.4% |
| 318 | Eczema Herpeticum | 7.4% |
| 319 | Carcinoma, Ehrlich Tumor | 7.4% |
| 320 | Dermoid Cyst | 7.4% |
| 321 | Carcinoma, Lewis Lung | 7.4% |
| 322 | Fusariosis | 7.4% |
| 323 | Carcinoid Tumor | 7.4% |
| 324 | Neurilemmoma | 7.4% |
| 325 | Hutchinson's Melanotic Freckle | 7.4% |
| 326 | Melanoma, Amelanotic | 7.4% |
| 327 | CREST Syndrome | 7.3% |
| 328 | Warts | 7.3% |
| 329 | Candidiasis, Chronic Mucocutaneous | 7.1% |
| 330 | Cutaneous Candidiasis | 7.1% |
| 331 | Transfusion Reaction | 7.1% |
| 332 | Hypotensive Transfusion Reaction | 7.1% |
| 333 | Erysipelas | 7.1% |
| 334 | Staphylococcal Skin Infections | 7.1% |
| 335 | Variegate Porphyria | 7.1% |
| 336 | Acute intermittent porphyria | 7.1% |
| 337 | Porphyria Cutanea Tarda | 7.1% |
| 338 | Erythrasma | 7.1% |
| 339 | Arthritis, Psoriatic | 7% |
| 340 | Cystadenocarcinoma | 6.9% |
| 341 | Mucoepidermoid Carcinoma | 6.9% |
| 342 | HIV-Associated Lipodystrophy Syndrome | 6.9% |
| 343 | Giant Cell Arteritis | 6.9% |
| 344 | Temporal Arteritis | 6.9% |
| 345 | Collagen Diseases | 6.8% |
| 346 | Mixed Connective Tissue Disease | 6.8% |
| 347 | Mucinoses | 6.8% |
| 348 | Leukemia, Radiation-Induced | 6.8% |
| 349 | Hodgkin Disease | 6.6% |
| 350 | Lymphoma, Non-Hodgkin | 6.6% |
| 351 | Astrocytoma | 6.5% |
| 352 | Ependymoma | 6.5% |
| 353 | oligodendroglioma | 6.5% |
| 354 | Ganglioglioma | 6.5% |
| 355 | gliosarcoma | 6.5% |
| 356 | Anaplastic astrocytoma | 6.5% |
| 357 | Anaplastic Oligodendroglioma | 6.5% |
| 358 | Cyst | 6.4% |
| 359 | Epidermodysplasia Verruciformis | 6.4% |
| 360 | Herpes Labialis | 6.4% |
| 361 | Neoplastic Processes | 6.4% |
| 362 | Neoplastic Syndromes, Hereditary | 6.4% |
| 363 | Pregnancy Complications, Neoplastic | 6.4% |
| 364 | Choriocarcinoma | 6.4% |
| 365 | Diabetic Foot | 6.4% |
| 366 | Neoplasms, Experimental | 6.3% |
| 367 | Staphylococcal Scalded Skin Syndrome | 6.3% |
| 368 | Multiple Myeloma | 6.3% |
| 369 | Thymoma | 6.1% |
| 370 | Malignant Carcinoid Syndrome | 6.1% |
| 371 | Malignant histiocytosis | 6% |
| 372 | Leukemia L1210 | 6% |
| 373 | Leukemia P388 | 6% |
| 374 | Histiocytic sarcoma | 6% |
| 375 | Acanthoma | 6% |
| 376 | Bowen's Disease | 5.9% |
| 377 | Paraganglioma | 5.9% |
| 378 | carbuncle | 5.9% |
| 379 | Rheumatoid Arthritis | 5.9% |
| 380 | Juvenile arthritis | 5.9% |
| 381 | Glioblastoma | 5.7% |
| 382 | Neuroblastoma | 5.7% |
| 383 | Glioblastoma Multiforme | 5.7% |
| 384 | Cartilage Diseases | 5.7% |
| 385 | Glomerulonephritis, Membranoproliferative | 5.7% |
| 386 | Rheumatism | 5.7% |
| 387 | Chondromalacia | 5.7% |
| 388 | Retinoblastoma | 5.6% |
| 389 | Condylomata Acuminata | 5.6% |
| 390 | Multiple Endocrine Neoplasia | 5.6% |
| 391 | Furunculosis | 5.6% |
| 392 | furuncle | 5.6% |
| 393 | Lymphomatoid Granulomatosis | 5.5% |
| 394 | Blastomycosis | 5.5% |
| 395 | Impetigo | 5.5% |
| 396 | Ganglioneuroblastoma | 5.3% |
| 397 | Neoplasms, Radiation-Induced | 5.2% |
| 398 | Antiphospholipid Syndrome | 5.1% |
| 399 | Rhinoscleroma | 5.1% |
| 400 | Scleromyxedema | 5% |
| 401 | Adenocarcinoma | 5% |
| 402 | Carcinoma in Situ | 5% |
| 403 | Carcinoma, Transitional Cell | 5% |
| 404 | Dysgerminoma | 5% |
| 405 | Hemangioendothelioma | 5% |
| 406 | Neuroma | 5% |
| 407 | Papilloma | 5% |
| 408 | Pseudomyxoma Peritonei | 5% |
| 409 | Seminoma | 5% |
| 410 | Papillomatosis | 5% |
| 411 | Adenomatosis, Pulmonary | 5% |
| 412 | Adenomatous Polyps | 5% |
| 413 | Carcinoma, Large Cell | 5% |
| 414 | Carcinoma, Small Cell | 5% |
| 415 | Leukemia, T-Cell | 4.9% |
| 416 | Leukemia, B-Cell | 4.9% |
| 417 | Pheochromocytoma | 4.9% |
| 418 | Autoimmune Lymphoproliferative Syndrome | 4.9% |
| 419 | Waldenstrom Macroglobulinemia | 4.8% |
| 420 | Carcinoid Heart Disease | 4.8% |
| 421 | Lupus Nephritis | 4.7% |
| 422 | Nephroblastoma | 4.6% |
| 423 | Lymphoma, Follicular | 4.6% |
| 424 | T-Cell Lymphoma | 4.6% |
| 425 | Mantle cell lymphoma | 4.6% |
| 426 | Paraneoplastic Encephalomyelitis | 4.6% |
| 427 | Menkes Kinky Hair Syndrome | 4.5% |
| 428 | Mammary Neoplasms, Experimental | 4.5% |
| 429 | Asthma | 4.4% |
| 430 | Abdominal Neoplasms | 4.3% |
| 431 | Erythroplasia | 4.3% |
| 432 | Follicular cyst | 4.3% |
| 433 | Head and Neck Neoplasms | 4.3% |
| 434 | Mucocele | 4.3% |
| 435 | Pilonidal Cyst | 4.3% |
| 436 | Soft Tissue Neoplasms | 4.3% |
| 437 | Thoracic Neoplasms | 4.3% |
| 438 | Thyroglossal Cyst | 4.3% |
| 439 | Synovial Cyst | 4.3% |
| 440 | Aberrant Crypt Foci | 4.3% |
| 441 | Felty Syndrome | 4.3% |
| 442 | Basal Cell Nevus Syndrome | 4.3% |
| 443 | Tuberous Sclerosis | 4.2% |
| 444 | Thrombocytopenic purpura | 4.2% |
| 445 | Asthma, Exercise-Induced | 4.2% |
| 446 | Status Asthmaticus | 4.2% |
| 447 | Lymphoproliferative Disorders | 4.1% |
| 448 | Addison Disease | 4.1% |
| 449 | Mesenteric Panniculitis | 4.1% |
| 450 | Panniculitis, Peritoneal | 4.1% |
| 451 | Paraproteinemias | 4.1% |
| 452 | Tietze's Syndrome | 4.1% |
| 453 | Orbital Cellulitis | 4.1% |
| 454 | Autoimmune thyroiditis | 4.1% |
| 455 | Primary Adrenal Insufficiency | 4.1% |
| 456 | Lymphopenia | 4.1% |
| 457 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4.1% |
| 458 | Autoimmune hepatitis | 4.1% |
| 459 | Sezary Syndrome | 4% |
| 460 | Acoustic Neuroma | 4% |
| 461 | Myxedema | 4% |
| 462 | Carcinoma, Pancreatic Ductal | 4% |
| 463 | Autoimmune thrombocytopenia | 4% |
| 464 | Immune thrombocytopenic purpura | 4% |
| 465 | Leukemia, Myelomonocytic, Chronic | 4% |
| 466 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4% |
| 467 | Cellulitis | 3.8% |
| 468 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.8% |
| 469 | Leukemia, Large Granular Lymphocytic | 3.8% |
| 470 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.8% |
| 471 | Mesoblastic Nephroma | 3.8% |
| 472 | Monoclonal Gammopathy of Undetermined Significance | 3.8% |
| 473 | Hepatocellular Adenoma | 3.8% |
| 474 | Aspergillosis, Allergic Bronchopulmonary | 3.7% |
| 475 | Adenoid Cystic Carcinoma | 3.7% |
| 476 | Adenocarcinoma, Clear Cell | 3.7% |
| 477 | Cholangiocarcinoma | 3.7% |
| 478 | Cervical Intraepithelial Neoplasia | 3.7% |
| 479 | Hemangioblastoma | 3.7% |
| 480 | Lymphoma, Extranodal NK-T-Cell | 3.7% |
| 481 | Rheumatoid Vasculitis | 3.7% |
| 482 | Optic Nerve Glioma | 3.7% |
| 483 | Lymphoma, T-Cell, Cutaneous | 3.7% |
| 484 | Lymphoma, AIDS-Related | 3.7% |
| 485 | Enteropathy-Associated T-Cell Lymphoma | 3.7% |
| 486 | Primary Effusion Lymphoma | 3.7% |
| 487 | Asthma, Occupational | 3.7% |
| 488 | Farmer's Lung | 3.6% |
| 489 | Hydatidiform Mole | 3.6% |
| 490 | Digestive System Neoplasms | 3.5% |
| 491 | Endocrine Gland Neoplasms | 3.5% |
| 492 | Eye Neoplasms | 3.5% |
| 493 | Nervous System Neoplasms | 3.5% |
| 494 | Hay fever | 3.5% |
| 495 | Rhinitis, Allergic, Perennial | 3.5% |
| 496 | Bone neoplasms | 3.4% |
| 497 | Leukoplakia | 3.4% |
| 498 | Lymphocele | 3.4% |
| 499 | Pancreatic Cyst | 3.4% |
| 500 | Hematologic Neoplasms | 3.4% |
| 501 | Hypergammaglobulinemia | 3.4% |
| 502 | Osteochondritis | 3.4% |
| 503 | Polymyalgia Rheumatica | 3.4% |
| 504 | Latent Autoimmune Diabetes in Adults | 3.4% |
| 505 | Vipoma | 3.4% |
| 506 | Barrett Esophagus | 3.4% |
| 507 | Mediastinal Cyst | 3.4% |
| 508 | Neoplasm Invasiveness | 3.4% |
| 509 | Neoplasm Metastasis | 3.4% |
| 510 | Neoplasm Recurrence, Local | 3.4% |
| 511 | Parovarian Cyst | 3.4% |
| 512 | Pericardial Cyst | 3.4% |
| 513 | Splenic Neoplasms | 3.4% |
| 514 | Thymic Cyst | 3.4% |
| 515 | Carcinogenesis | 3.4% |
| 516 | Metastasis | 3.4% |
| 517 | Agammaglobulinemia | 3.4% |
| 518 | HIV Infections | 3.4% |
| 519 | Osteogenesis Imperfecta | 3.4% |
| 520 | Sturge-Weber Syndrome | 3.4% |
| 521 | Transfusion-Related Acute Lung Injury | 3.4% |
| 522 | Lambert-Eaton Myasthenic Syndrome | 3.4% |
| 523 | Multiple Endocrine Neoplasia Type 1 | 3.3% |
| 524 | Hemangioma, Cavernous | 3.3% |
| 525 | Keloid | 3.3% |
| 526 | Sicca Syndrome | 3.3% |
| 527 | Sjogren's Syndrome | 3.3% |
| 528 | Prolactinoma | 3.3% |
| 529 | Growth Hormone-Secreting Pituitary Adenoma | 3.3% |
| 530 | neurofibroma | 3.3% |
| 531 | Mycosis Fungoides | 3.2% |
| 532 | Lymphomatoid Papulosis | 3.2% |
| 533 | Plasmablastic lymphoma | 3.2% |
| 534 | Klatskin Tumor | 3.1% |
| 535 | Lupus Vasculitis, Central Nervous System | 3% |
| 536 | Noonan Syndrome | 3% |
| 537 | Leukemia, Myeloid, Chronic-Phase | 3% |
| 538 | Liver Neoplasms, Experimental | 2.9% |
| 539 | Adenomatous Polyposis Coli | 2.9% |
| 540 | Parathyroid Neoplasms | 2.9% |
| 541 | Peritoneal Neoplasms | 2.9% |
| 542 | Thyroid Neoplasm | 2.9% |
| 543 | Thyroid carcinoma | 2.9% |
| 544 | granulosa cell tumor | 2.9% |
| 545 | Carcinoma, Ovarian Epithelial | 2.9% |
| 546 | Graves Disease | 2.9% |
| 547 | Anti-Glomerular Basement Membrane Disease | 2.9% |
| 548 | Corpus Luteum Cyst | 2.8% |
| 549 | Ovarian Cysts | 2.8% |
| 550 | Rheumatoid Nodule | 2.8% |
| 551 | Burkitt Lymphoma | 2.8% |
| 552 | insulinoma | 2.7% |
| 553 | Marfan Syndrome | 2.7% |
| 554 | Tumor Lysis Syndrome | 2.7% |
| 555 | HTLV-I Infections | 2.7% |
| 556 | Job Syndrome | 2.7% |
| 557 | Homocystinuria | 2.6% |
| 558 | Pancreatic Neoplasm | 2.6% |
| 559 | Laryngomalacia | 2.6% |
| 560 | Pectus carinatum | 2.6% |
| 561 | Retroperitoneal Neoplasms | 2.5% |
| 562 | Schnitzler Syndrome | 2.5% |
| 563 | Adrenocortical carcinoma | 2.4% |
| 564 | Choledochal Cyst | 2.4% |
| 565 | Gastrinoma | 2.4% |
| 566 | Glucagonoma | 2.4% |
| 567 | Tracheal Neoplasms | 2.4% |
| 568 | Myelitis, Transverse | 2.4% |
| 569 | Leukoplakia, Oral | 2.4% |
| 570 | Bronchomalacia | 2.4% |
| 571 | Paraneoplastic Cerebellar Degeneration | 2.4% |
| 572 | Tracheomalacia | 2.4% |
| 573 | Nasopharyngeal carcinoma | 2.4% |
| 574 | Leydig Cell Tumor | 2.3% |
| 575 | Myasthenia Gravis | 2.3% |
| 576 | Uveomeningoencephalitic Syndrome | 2.3% |
| 577 | Kernicterus | 2.2% |
| 578 | Chronic granulomatous disease | 2.2% |
| 579 | Heavy Chain Disease | 2.2% |
| 580 | Granulomatosis with polyangiitis | 2.2% |
| 581 | Denys-Drash Syndrome | 2.2% |
| 582 | HIV Seropositivity | 2.2% |
| 583 | Myasthenia Gravis, Autoimmune, Experimental | 2.2% |
| 584 | Renal Cell Carcinoma | 2.2% |
| 585 | Papillary Renal Cell Carcinoma | 2.2% |
| 586 | Esophageal Neoplasms | 2.1% |
| 587 | Carcinoma, Endometrioid | 2.1% |
| 588 | Limbic Encephalitis | 2.1% |
| 589 | Mouth Neoplasms | 2% |
| 590 | Central Nervous System Neoplasms | 2% |
| 591 | Vascular Neoplasms | 2% |
| 592 | Thymus Neoplasms | 2% |
| 593 | Mucopolysaccharidosis III | 2% |
| 594 | Ataxia Telangiectasia | 2% |
| 595 | Genital Neoplasms, Female | 2% |
| 596 | Pancreatic Pseudocyst | 2% |
| 597 | Lymphatic Metastasis | 2% |
| 598 | Neoplasms, Unknown Primary | 2% |
| 599 | Leukemic Infiltration | 2% |
| 600 | Neoplasm Micrometastasis | 2% |
| 601 | Hydrops Fetalis | 2% |
| 602 | Stiff-Person Syndrome | 2% |
| 603 | Polyradiculoneuropathy | 1.9% |
| 604 | Polyradiculoneuritis | 1.9% |
| 605 | Acquired Immunodeficiency Syndrome | 1.9% |
| 606 | AIDS related complex | 1.9% |
| 607 | Infectious Mononucleosis | 1.9% |
| 608 | Cryoglobulinemia | 1.9% |
| 609 | Thyroid Nodule | 1.9% |
| 610 | POEMS Syndrome | 1.9% |
| 611 | Testicular Neoplasms | 1.9% |
| 612 | Adrenal Gland Neoplasms | 1.7% |
| 613 | Gastrointestinal Neoplasms | 1.7% |
| 614 | Genital Neoplasms, Male | 1.7% |
| 615 | Liver neoplasms | 1.7% |
| 616 | Uveal Neoplasms | 1.7% |
| 617 | Urologic Neoplasms | 1.7% |
| 618 | AIDS-Related Opportunistic Infections | 1.7% |
| 619 | Vasculitis, Central Nervous System | 1.7% |
| 620 | Spinal Neoplasms | 1.7% |
| 621 | Bone Marrow Neoplasms | 1.7% |
| 622 | Opsoclonus-Myoclonus Syndrome | 1.7% |
| 623 | Multiple Sclerosis | 1.7% |
| 624 | HIV Wasting Syndrome | 1.7% |
| 625 | Polycystic Ovary Syndrome | 1.7% |
| 626 | AIDS Dementia Complex | 1.6% |
| 627 | AIDS-Associated Nephropathy | 1.6% |
| 628 | Neuromyelitis Optica | 1.6% |
| 629 | Leukoencephalitis, Acute Hemorrhagic | 1.6% |
| 630 | Wiskott-Aldrich Syndrome | 1.5% |
| 631 | Mucopolysaccharidosis II | 1.5% |
| 632 | Encephalomyelitis, Acute Disseminated | 1.4% |
| 633 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1.4% |
| 634 | Neuritis, Autoimmune, Experimental | 1.4% |
| 635 | Multiple Sclerosis, Chronic Progressive | 1.4% |
| 636 | Multiple Sclerosis, Relapsing-Remitting | 1.4% |
| 637 | Nose Neoplasms | 1.4% |
| 638 | Meningeal Neoplasms | 1.3% |
| 639 | Palatal Neoplasms | 1.3% |
| 640 | ovarian neoplasm | 1.3% |
| 641 | Guillain-Barre Syndrome | 1.2% |
| 642 | Pituitary Adenoma | 1.2% |
| 643 | Pituitary Neoplasms | 1.2% |
| 644 | Ear Neoplasms | 1.1% |
| 645 | Eyelid Neoplasms | 1.1% |
| 646 | Lung Neoplasms | 1.1% |
| 647 | Pleural Neoplasms | 1.1% |
| 648 | Cell Transformation, Viral | 1.1% |
| 649 | Brain Neoplasms | 1.1% |
| 650 | Salivary Gland Neoplasms | 1.1% |
| 651 | Spinal Cord Neoplasms | 1.1% |
| 652 | Tongue Neoplasms | 1.1% |
| 653 | Uterine Neoplasms | 1.1% |
| 654 | Vaginal Neoplasms | 1.1% |
| 655 | Vulvar Neoplasms | 1.1% |
| 656 | Uterine Cancer | 1.1% |
| 657 | Fallopian Tube Neoplasms | 1.1% |
| 658 | Zollinger-Ellison syndrome | 1% |
| 659 | Meningeal Carcinomatosis | 1% |
| 660 | Pharyngeal Neoplasms | 1% |
| 661 | Central Nervous System Cysts | 1% |
| 662 | Bile Duct Neoplasms | 1% |
| 663 | gallbladder neoplasm | 1% |
| 664 | Intestinal Neoplasms | 1% |
| 665 | Penile Neoplasms | 1% |
| 666 | Prostatic Neoplasms | 1% |
| 667 | Stomach Neoplasms | 1% |
| 668 | Polycythemia Vera | 0.9% |
| 669 | Laryngeal neoplasm | 0.9% |
| 670 | Bronchial Neoplasms | 0.8% |
| 671 | Multiple Pulmonary Nodules | 0.8% |
| 672 | Bladder Neoplasm | 0.8% |
| 673 | Kidney Neoplasm | 0.8% |
| 674 | Ureteral Neoplasms | 0.8% |
| 675 | Urethral Neoplasms | 0.8% |
| 676 | Supratentorial Neoplasms | 0.8% |
| 677 | Endometrial Neoplasms | 0.8% |
| 678 | Miller Fisher Syndrome | 0.7% |
| 679 | Hypopharyngeal Neoplasms | 0.7% |
| 680 | Pleural Effusion, Malignant | 0.7% |
| 681 | Hypopharyngeal Cancer | 0.7% |
| 682 | Parotid Neoplasms | 0.7% |
| 683 | Prostatic Neoplasms, Castration-Resistant | 0.7% |
| 684 | Nelson Syndrome | 0.7% |
| 685 | Brain Stem Neoplasms | 0.7% |
| 686 | Cecal Neoplasms | 0.6% |
| 687 | Duodenal Neoplasms | 0.6% |
| 688 | Choroid Plexus Papilloma | 0.6% |
| 689 | Tonsillar Neoplasms | 0.6% |
| 690 | Cerebellar Neoplasms | 0.6% |
| 691 | Nasopharyngeal Neoplasms | 0.6% |
| 692 | Colorectal Neoplasms | 0.5% |
| 693 | Radicular Cyst | 0.5% |
| 694 | Appendiceal Neoplasms | 0.5% |
| 695 | Colonic Neoplasms | 0.5% |
| 696 | Rectal Neoplasms | 0.5% |
| 697 | Paranasal Sinus Neoplasms | 0.5% |
| 698 | Maxillary Sinus Neoplasms | 0.4% |
| 699 | Anus Neoplasms | 0.4% |
| 700 | Sigmoid Neoplasms | 0.4% |